Sailaja Puttagunta
Impact in
-
- Antibiotic Use and Resistance
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antimicrobial Resistance in Staphylococcus 14
- Pharmacology 13
- Antibiotics Pharmacokinetics and Efficacy 13
- Co-authors
- Michael W. Dunne (32 shared papers)Helen W. Boucher (5 shared papers)George H. Talbot (4 shared papers)Anita Das (6 shared papers)James Baldassarre (3 shared papers)Mark Wilcox (1 shared paper)Michael T. Zelasky (5 shared papers)Chris Rubino (1 shared paper)
- Journals
- Open Forum Infectious Diseases (12 papers)Antimicrobial Agents and Chemotherapy (4 papers)Clinical Infectious Diseases (3 papers)Infectious Diseases and Therapy (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)
- Partner nations
- United StatesUnited KingdomLatvia
In The Last Decade
Sailaja Puttagunta
45 papers receiving 1.6k citations
Sailaja Puttagunta's Hit Papers
Peers
Comparison fields: 5 of 85
- Applied Microbiology and Biotechnology 138
- Clinical Biochemistry 286
- Molecular Medicine 215
- Infectious Diseases 702
- Pharmacology 314
Countries citing papers authored by Sailaja Puttagunta
This map shows the geographic impact of Sailaja Puttagunta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sailaja Puttagunta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sailaja Puttagunta more than expected).
Fields of papers citing papers by Sailaja Puttagunta
This network shows the impact of papers produced by Sailaja Puttagunta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sailaja Puttagunta. The network helps show where Sailaja Puttagunta may publish in the future.
Co-authors
The 25 scholars most cited alongside Sailaja Puttagunta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection Hit paper breakdown → | 2014 | 333 |
| 2 | 2015 | 183 | |
| 3 | 2015 | 176 | |
| 4 | 2018 | 157 | |
| 5 | 1996 | 105 | |
| 6 | 2013 | 73 | |
| 7 | 2015 | 58 | |
| 8 | 2015 | 40 | |
| 9 | 2014 | 40 | |
| 10 | 2017 | 34 | |
| 11 | 2015 | 33 | |
| 12 | 2018 | 32 | |
| 13 | 2019 | 31 | |
| 14 | 1994 | 31 | |
| 15 | 2022 | 29 | |
| 16 | 2022 | 27 | |
| 17 | 2022 | 26 | |
| 18 | 2022 | 25 | |
| 19 | 2012 | 23 | |
| 20 | 2018 | 20 |
About Sailaja Puttagunta
Sailaja Puttagunta is a scholar working on Infectious Diseases, Pharmacology, Epidemiology, Molecular Biology and Molecular Medicine, having authored 45 papers that have together received 1.6k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (14 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers), Urinary Tract Infections Management (9 papers), Antibiotic Resistance in Bacteria (5 papers), Antibiotic Use and Resistance (4 papers), Bacteriophages and microbial interactions (4 papers), Bacterial Identification and Susceptibility Testing (3 papers) and Pharmaceutical studies and practices (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (138 citations), Clinical Biochemistry (286 citations), Molecular Medicine (215 citations), Infectious Diseases (702 citations) and Pharmacology (314 citations). Sailaja Puttagunta has collaborated with scholars based in United States, United Kingdom and Latvia. Frequent co-authors include Michael W. Dunne, Helen W. Boucher, George H. Talbot, Anita Das, James Baldassarre, Mark Wilcox, Michael T. Zelasky, Chris Rubino, Scott Van Wart and Dainis Krieviņš. Their work appears in journals such as Open Forum Infectious Diseases, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, Infectious Diseases and Therapy and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.